Skip to content

Cancer Health Center

Font Size

Treatment Options for Chronic Myeloproliferative Disorders

    A link to a list of current clinical trials is included for each treatment section. For some types or stages of cancer, there may not be any trials listed. Check with your doctor for clinical trials that are not listed here but may be right for you.

    Chronic Myelogenous Leukemia

    Recommended Related to Cancer

    Pheochromocytoma During Pregnancy

    Pheochromocytoma diagnosed during pregnancy is extremely rare (0.007% of all pregnancies).[1,2] However, this situation deserves mention because women with hereditary conditions that increase the risk of developing pheochromocytoma are often also of child-bearing age, and the outcome of undiagnosed pheochromocytoma during pregnancy can be catastrophic. Diagnosis Prenatal diagnosis clearly results in decreased mortality for both mother and neonate.[3] Prior to 1970, a prenatal diagnosis of...

    Read the Pheochromocytoma During Pregnancy article > >

    See the PDQ summary about Chronic Myelogenous Leukemia Treatment for information.

    Polycythemia Vera

    The purpose of treatment for polycythemia vera is to reduce the number of extra blood cells. Treatment of polycythemia vera may include the following:

    Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with polycythemia vera. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.

    Primary Myelofibrosis

    Treatment of primary myelofibrosis in patients without symptoms is usually watchful waiting.

    Patients with primary myelofibrosis may have symptoms of anemia. Anemia is usually treated with transfusion of red blood cells to relieve symptoms and improve quality of life. In addition, anemia may be treated with:

    Treatment of primary myelofibrosis in patients with other symptoms may include the following:

    • Targeted therapy with ruxolitinib.
    • Chemotherapy.
    • Donor stem cell transplant.
    • Thalidomide, lenalidomide, or pomalidomide.
    • Splenectomy.
    • Radiation therapy to the spleen, lymph nodes, or other areas outside the bone marrow where blood cells are forming.
    • Biologic therapy using interferon alfa or erythropoietic growth factors.
    • A clinical trial of other targeted therapy drugs.

    Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with primary myelofibrosis. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.

      1|2

      Today on WebMD

      Colorectal cancer cells
      A common one in both men and women.
      Lung cancer xray
      See it in pictures, plus read the facts.
       
      sauteed cherry tomatoes
      Fight cancer one plate at a time.
      Ovarian cancer illustration
      Do you know the symptoms?
       
      Jennifer Goodman Linn self-portrait
      Blog
      what is your cancer risk
      HEALTH CHECK
       
      colorectal cancer treatment advances
      Video
      breast cancer overview slideshow
      SLIDESHOW
       
      prostate cancer overview
      SLIDESHOW
      lung cancer overview slideshow
      SLIDESHOW
       
      ovarian cancer overview slideshow
      SLIDESHOW
      Actor Michael Douglas
      Article